PURA to launch Farmersville Hemp brand marketing campaign



DALLAS, TX, September 21, 2021 (GLOBE NEWSWIRE) – Puration, Inc. (OTC Pink: PURA) (“PURA”) has launched a strategic industry-wide hemp initiative to collectively market multiple growers and processors of hemp under a single brand name – Farmersville Hemp.

PURA has already partnered with Alkame Holdings, Inc. (OTC Pink: ALKM), North American Cannabis Holdings, Inc. (OTC Pink: USMJ) and PAO Group, Inc. (OTC Pink: PAOG).

At the start of the fourth quarter, PURA intends to launch a marketing campaign to expand its partnership base.

The company recently broke new ground on its 70-acre property in Farmersville, Texas. A construction platform has been cleared for the construction of several buildings where PURA will facilitate the practical marketing of a wide variety of products that can be derived from hemp.

Farmersville’s branded hemp facility will be able to host corporate clients for seminars to demonstrate the processing of hemp and how hemp can be used as a natural, cost-effective and even superior alternative to building materials, nutraceuticals and pharmaceuticals today. available, clothing, fuel and plastics – to name a few. According to a source, more than 25,000 products can be made from hemp.

PURA builds processing and cultivation partners with the goal of establishing an industrial hemp brand cooperative under the Farmersville Hemp brand name. Fashionable who Sun-Maid Grapes Collectively markets growers all selling under one brand, PURA plans to collectively market multiple hemp growers and processors under the Farmersville Hemp brand.

For more information on Purification, visit http://www.purationinc.com

Purification, Inc.
Brian Shibley,
[email protected]
+1 (800) 861-1350

Disclaimer / Safe Harbor: This press release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company’s current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that Alkame will achieve significant sales, non-compliance with the timetable or performance requirements of the Company’s contracts, the Company’s liquidity situation, the Company’s ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive prices. In light of these uncertainties, the forward-looking events mentioned in this press release may not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.



Comments are closed.